Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

BioNexus Gene Lab Corp Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Mar-31-21Dec-31-20Mar-31-20Dec-31-19Dec-31-18Dec-31-17
Revenues10.913.413.411.411.40.10.20.1
            Revenue growth-18.2%17.3%17.3%8872.0% -40.2%97.2% 
Cost of goods sold11.211.211.29.79.70.10.20.0
Gross profit-0.32.22.21.71.70.10.00.1
            Gross margin-2.7%16.4%16.4%15.1%15.1%44.0%13.5%73.2%
Selling, general and administrative-11.2      0.2
General and administrative 1.21.21.31.30.40.2 
EBIT-0.31.13.41.33.1-0.30.1-0.1
            EBIT margin-2.7%7.9%25.4%11.2%26.8%-217.2%28.2%-110.9%
Pre-tax income-0.31.01.01.31.3-0.30.0-0.1
Income taxes0.10.0-0.30.0-0.20.00.00.0
            Tax rate   0.1%  478.3%3.4%
Net income-0.40.80.01.10.0-0.20.0-0.1
            Net margin-3.3%5.6%0.0%9.6%0.0%-194.1%12.5%-114.9%
 
Diluted EPS$0.00$0.00$0.00$0.01$0.00$0.00$0.00$0.00
Shares outstanding (diluted)172.9171.2171.2102.9102.986.466.353.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy